Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
CHINOOK THERAPEUTICS INC
About KDNY
Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering, developing and commercializing precision medicines for kidney diseases. Its lead product candidate is atrasentan, a potent and selective endothelin A receptor (ET A receptor), antagonist that is developing for the treatment of proteinuric glomerular diseases. Atrasentan is in Phase III trials for the treatment of IgA nephropathy (IgAN) and proteinuric glomerular diseases. Its second product candidate, BION-1301, is an anti-APRIL monoclonal antibody also in Phase II development for patients with IgAN. Its third product candidate, CHK-336, is an oral small molecule lactate dehydrogenase (LDHA), inhibitor for the treatment of primary and idiopathic hyperoxaluria that is in a Phase I clinical trial in healthy volunteers. In addition, the Company is also conducting research programs in several other rare, severe chronic kidney diseases.
Find out what a historical investment in CHINOOK THERAPEUTICS INC would be worth today using our KDNY stock calculator.
Market Capitalisation
-
Price-earnings ratio
-
Dividend yield
-
Volume
-
High today
-
Low today
-
Open price
-
52-week high
-
52-week low
-
Ready to start your investing journey with Stake?
Open an accountHow do I buy KDNY shares in Australia?
Buying KDNY shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in CHINOOK THERAPEUTICS INC in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in KDNY
What is the ticker symbol of CHINOOK THERAPEUTICS INC?
The ticker symbol for CHINOOK THERAPEUTICS INC is KDNY.
How much is one share of KDNY?
One share of KDNY is valued at $40.30 as of 16 May 2026.
What is the market capitalisation of CHINOOK THERAPEUTICS INC KDNY?
As of 16 May 2026 CHINOOK THERAPEUTICS INC has a market cap of -.
What is the 52-week high for CHINOOK THERAPEUTICS INC stock?
The CHINOOK THERAPEUTICS INC 52-week high stock price is $NaN.
What is the 52-week low for CHINOOK THERAPEUTICS INC stock?
The CHINOOK THERAPEUTICS INC 52-week low stock price is $NaN.
Can I buy KDNY shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy KDNY shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in KDNY on Stake
- Buy KDNY from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of KDNY from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
KDNY related stocks